Alemtuzumab by continuous intravenous infusion followed by subcutaneous injection plus rituximab in the treatment of patients with chronic lymphocytic leukemia recurrence

Stefan Faderl, Alessandra Ferrajoli, William Wierda, Susan O'Brien, Susan Lerner, Michael J. Keating

Research output: Contribution to journal › Article › peer-review

41 Scopus citations

Fingerprint

Dive into the research topics of 'Alemtuzumab by continuous intravenous infusion followed by subcutaneous injection plus rituximab in the treatment of patients with chronic lymphocytic leukemia recurrence'. Together they form a unique fingerprint.

Medicine & Life Sciences